These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16245460)

  • 1. [Silver coated urinary catheters. Clinical effectiveness and cost-benefit analysis].
    Panknin HT
    Med Monatsschr Pharm; 2005 Oct; 28(10):368-70. PubMed ID: 16245460
    [No Abstract]   [Full Text] [Related]  

  • 2. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K; Lam TB
    Neurourol Urodyn; 2008; 27(8):738-46. PubMed ID: 18951451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance.
    Rupp ME; Fitzgerald T; Marion N; Helget V; Puumala S; Anderson JR; Fey PD
    Am J Infect Control; 2004 Dec; 32(8):445-50. PubMed ID: 15573050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comment re: Types of urethral catheters for management of short-term voiding problems in hospitalized adults.
    Feneley R
    Neurourol Urodyn; 2008; 27(8):747. PubMed ID: 18951450
    [No Abstract]   [Full Text] [Related]  

  • 5. Comment re: Types of urethral catheters for management of short-term voiding problems in hospitalized adults.
    Stickler D
    Neurourol Urodyn; 2008; 27(8):748. PubMed ID: 18951443
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-infective catheters: novel strategies to prevent nosocomial infections in oncology.
    Schierholz JM; Rump AF; Pulverer G; Beuth J
    Anticancer Res; 1998; 18(5B):3629-38. PubMed ID: 9854469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silver-coated catheter reduces hospital UTIs, associated costs.
    Health Care Cost Reengineering Rep; 1999 Jan; 4(1):13-4, 1. PubMed ID: 10345816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are antiseptic-coated central venous catheters effective in a real-world setting?
    Borschel DM; Chenoweth CE; Kaufman SR; Hyde KV; VanDerElzen KA; Raghunathan TE; Collins CD; Saint S
    Am J Infect Control; 2006 Aug; 34(6):388-93. PubMed ID: 16877109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized trial of rifampicin-minocycline-coated and silver-platinum-carbon-impregnated central venous catheters.
    Fraenkel D; Rickard C; Thomas P; Faoagali J; George N; Ware R
    Crit Care Med; 2006 Mar; 34(3):668-75. PubMed ID: 16505651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for the use of silver-alloy-coated urethral catheters.
    Davenport K; Keeley FX
    J Hosp Infect; 2005 Aug; 60(4):298-303. PubMed ID: 15936115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosocomial urinary tract infection.
    Ksycki MF; Namias N
    Surg Clin North Am; 2009 Apr; 89(2):475-81, ix-x. PubMed ID: 19281895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical use of antiseptic and antibiotic impregnated catheters].
    Lefrant JY
    Ann Fr Anesth Reanim; 2005 Mar; 24(3):291-3. PubMed ID: 15792566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silver-coated dressing market booms as manufacturers 'jump on bandwagon'.
    Hosp Mater Manage; 2007 Aug; 32(8):1, 6-7. PubMed ID: 17726819
    [No Abstract]   [Full Text] [Related]  

  • 14. Strategies for preventing catheter-related bloodstream infections: the role of new technologies.
    Lubelchek RJ; Weinstein RA
    Crit Care Med; 2006 Mar; 34(3):905-7. PubMed ID: 16505678
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness in the use of antibiotics.
    McNabb J; Quintiliani R; Nicolau DP; Grant E; Nightingale CH
    Curr Clin Top Infect Dis; 2000; 20():24-42. PubMed ID: 10943517
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of crosslinking effects on the physicochemical and drug diffusional properties of cationic hydrogels designed as bioactive urological biomaterials.
    Jones DS; Andrews GP; Gorman SP
    J Pharm Pharmacol; 2005 Oct; 57(10):1251-59. PubMed ID: 16259753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link?
    Falcone M; Giannella M; Raponi G; Mancini C; Venditti M
    Clin Microbiol Infect; 2006 Jan; 12(1):96-7. PubMed ID: 16460556
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness of linezolid and vancomycin in the treatment of surgical site infections.
    Patanwala AE; Erstad BL; Nix DE
    Curr Med Res Opin; 2007 Jan; 23(1):185-93. PubMed ID: 17257479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems of updating antibacterial therapy].
    Alekseev GK
    Klin Med (Mosk); 1999; 77(3):4-8. PubMed ID: 10234937
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-adherence activity and antimicrobial durability of anti-infective-coated catheters against multidrug-resistant bacteria.
    Raad I; Reitzel R; Jiang Y; Chemaly RF; Dvorak T; Hachem R
    J Antimicrob Chemother; 2008 Oct; 62(4):746-50. PubMed ID: 18653489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.